Splash Pharmaceuticals logo

Splash Pharmaceuticals

1 employees · est. 2016 · San Diego, United States

VS
Tarveda Therapeutics logo

Tarveda Therapeutics

To discover, develop and commercialize a new class of potent and selective precision oncology medicines.

5 employees · est. 2011 · Watertown, United States

Tarveda Therapeutics is the older company (2016 vs 2011); Tarveda Therapeutics is the larger of the two.

Side-by-Side Comparison

Splash Pharmaceuticals Tarveda Therapeutics
Founded
2016 2011 older
Headquarters
San Diego, United States Watertown, United States
Employees
1 5 larger
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series D Unknown
Total Funding
$22.99M $119.80M
Funding Rounds
4 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical Stage Pharmaceuticals, Oncology Therapies, Cancer Target Therapies, CD44 Targeted Agents, Anti-Angiogenic Therapies, Anti-Metastatic Therapies, Cytotoxicity, Pharmaceutical Development, Clinical Trials, Pharma Partnerships Precision Oncology, Biopharmaceuticals, Drug Development, Solid Tumor Treatment, Miniature Drug Conjugates, Pentarin Technology, Targeted Cancer Therapy, HSP90 Binding, Topoisomerase 1 Inhibitor, Phase 2a Clinical Trials, Cancer Payload Delivery, Somatostatin Receptor 2 Therapy, Kinase Inhibitors, Radioisotope Drug Conjugates, Neuroendocrine Tumor Treatment
Website
splashpharma.com tarvedatx.com
Splash Pharmaceuticals logo

About Splash Pharmaceuticals

Splash Pharmaceuticals is a privately held clinical stage oncology pharmaceutical company founded in 2001. It is focused on advancing innovative therapies against a novel and pivotal cancer target. The lead therapy has completed multiple Phase I and II clinical trials with promising results. The las...

Tarveda Therapeutics logo

About Tarveda Therapeutics

Tarveda Therapeutics, founded in 2011, is a clinical-stage biopharmaceutical company focused on developing a new class of potent and selective precision oncology medicines. Its cutting-edge technology, branded as Pentarin® miniature drug conjugates, targets solid tumor malignancies. These conjugates...

We will tell you when either one moves

BounceWatch watches Splash Pharmaceuticals and Tarveda Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Splash Pharmaceuticals and Tarveda Therapeutics — by email.

Frequently Asked Questions

Splash Pharmaceuticals. Tarveda Therapeutics — To discover, develop and commercialize a new class of potent and selective precision oncology medicines. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Splash Pharmaceuticals has raised $22.99M while Tarveda Therapeutics has raised $119.80M.
Splash Pharmaceuticals and Tarveda Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Splash Pharmaceuticals with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Splash Pharmaceuticals on 11 Sep 2024, and Tarveda Therapeutics on 13 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes